April 4, 2026

What Does Spravato Feel Like? If you’re considering Spravato for depression, it’s completely natural to wonder what the experience will actually feel like, physically, emotionally, and mentally. In this guide, we’ll walk you through what Spravato is, its common effects, and how we help create a safe, supportive experience for patients here at McLean.  Understanding

Read More

March 30, 2026

Political Depression and How to Treat It in DC Washington, D.C., sits at the intersection of politics, media scrutiny, and civic engagement. For residents, professionals, and frequent visitors, this environment can create intense psychological pressures. Political depression, meaning sustained low mood or chronic stress triggered by political events, is increasingly common in the city. Unlike

Read More

March 24, 2026

Seasonal Affective Disorder: Guide and Treatment Options Many individuals notice changes in their mood as the days shorten, but seasonal mood shifts are more than a mild case of the “winter blues.” This condition, clinically known as Seasonal Affective Disorder (SAD), is a recurrent form of depression that can significantly interfere with daily functioning and

Read More

March 18, 2026

Psychiatrists for Depression in Washington, DC Depression remains one of the most common and disabling mental health conditions, affecting millions of adults nationwide. For individuals experiencing severe or treatment-resistant depression, accessing specialized psychiatric care can make a profound difference in recovery and quality of life. McLean Hospital, a leading psychiatric institution affiliated with Harvard Medical

Read More

February 5, 2026

Depression affects millions of people and often persists despite sincere effort, commitment to treatment, and the best available care. Many people move through cycles of medication adjustments, therapy sessions, lifestyle changes, and still feel as though something remains stuck. Into this landscape comes a treatment with momentum, clarity, and solid evidence: magnetic stimulation, known clinically

Read More

January 29, 2026

Intranasal ketamine (esketamine) or Spravato offers a new path for people who have not found relief with traditional treatments for depression and other mood disorders. Carefully monitored nasal-spray protocols are becoming more accessible as a treatment option. They act quickly, integrate smoothly into structured mental-health programs, and support recovery in a compassionate, clinically rigorous setting.

Read More